{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T10:10:24Z","timestamp":1789726224645,"version":"4.0.1"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2019,1,21]],"date-time":"2019-01-21T00:00:00Z","timestamp":1548028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,2,1]]},"DOI":"10.1093\/ajhp\/zxy036","type":"journal-article","created":{"date-parts":[[2019,1,21]],"date-time":"2019-01-21T03:38:32Z","timestamp":1548041912000},"page":"206-210","source":"Crossref","is-referenced-by-count":9,"title":["Musculoskeletal toxicities in patients receiving concomitant statin and daptomycin therapy"],"prefix":"10.1093","volume":"76","author":[{"given":"Kazuhiko","family":"Kido","sequence":"first","affiliation":[{"name":"College of Pharmacy Allied Health Professions, South Dakota State University, Sioux Falls, SD"},{"name":"Department of Pharmacy Practice, Avera McKennan Hospital, Sioux Falls, SD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austin A","family":"Oyen","sequence":"additional","affiliation":[{"name":"College of Pharmacy Allied Health Professions, South Dakota State University, Sioux Falls, SD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan A","family":"Beckmann","sequence":"additional","affiliation":[{"name":"College of Pharmacy Allied Health Professions, South Dakota State University, Sioux Falls, SD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara D","family":"Brouse","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Texas Tech University Health Sciences Center, Abilene, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,1,21]]},"reference":[{"key":"2019061104405602700_CIT0001","volume-title":"Cubicin (daptomycin) package insert.","year":"2015"},{"key":"2019061104405602700_CIT0002","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1161\/01.cir.0000437738.63853.7a","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults. A report of the American College of Cardiology\/American Heart Association task force on practice guidelines","volume":"129","author":"Stone","year":"2014","journal-title":"Circulation."},{"key":"2019061104405602700_CIT0003","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1515\/dmdi-2012-0033","article-title":"Statins and daptomycin: safety assessment of concurrent use and evaluation of drug interaction liability","volume":"28","author":"Golightly","year":"2013","journal-title":"Drug Metabol Drug Interact."},{"key":"2019061104405602700_CIT0004","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/mus.21691","article-title":"Characterization of skeletal muscle effects associated with daptomycin in rats","volume":"42","author":"Kostrominova","year":"2010","journal-title":"Muscle Nerve."},{"key":"2019061104405602700_CIT0005","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S1734-1140(11)70601-6","article-title":"Statin-induced myopathies","volume":"63","author":"Tomaszewski","year":"2011","journal-title":"Pharmacol Rep."},{"key":"2019061104405602700_CIT0006","doi-asserted-by":"crossref","first-page":"960363","DOI":"10.1155\/2012\/960363","article-title":"Creatine-kinase- and exercise-related muscle damage implications for muscle performance and recovery","volume":"2012","author":"Baird","year":"2012","journal-title":"J Nutr Metab."},{"key":"2019061104405602700_CIT0007","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0735-1097(02)02030-2","article-title":"ACC\/AHA\/NHLBI clinical advisory on the use and safety of statins","volume":"40","author":"Pasternak","year":"2002","journal-title":"J Am Coll Cardiol."},{"key":"2019061104405602700_CIT0008","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1086\/600039","article-title":"Safety of high-dose intravenous daptomycin treatment: three-year cumulative experience in a clinical program","volume":"49","author":"Figueroa","year":"2009","journal-title":"Clin Infect Dis."},{"key":"2019061104405602700_CIT0009","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1093\/jac\/dkp127","article-title":"Rhabdomyolysis and acute renal failure associated with the co-administration of daptomycin and an HMG-coa reductase inhibitor","volume":"63","author":"Odero","year":"2009","journal-title":"J Antimicrob Chemother."},{"key":"2019061104405602700_CIT0010","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ijantimicag.2011.08.003","article-title":"Successful re-challenge of daptomycin therapy after initial rhabdomyolysis with co-administration of simvastatin","volume":"38","author":"Bland","year":"2011","journal-title":"Int J Antimicrob Agents."},{"key":"2019061104405602700_CIT0011","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s40121-014-0041-y","article-title":"Effect of concomitant 3-hydroxy-3-methyl-glutaryl-CoA reductase inhibitor therapy on creatine phosphokinase levels and mortality among patients receiving daptomycin: retrospective cohort study","volume":"3","author":"McConnell","year":"2014","journal-title":"Infect Dis Ther."},{"key":"2019061104405602700_CIT0012","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1177\/1060028013514377","article-title":"Evaluation of impact of statin use on development of CPK elevation during daptomycin therapy","volume":"48","author":"Berg","year":"2014","journal-title":"Ann Pharmacother."},{"key":"2019061104405602700_CIT0013","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1007\/s10096-011-1500-y","article-title":"Safety analysis of high dose (> 6 mg\/kg\/day) daptomycin in patients with concomitant statin therapy","volume":"31","author":"Parra-Ruiz","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis."},{"key":"2019061104405602700_CIT0014","first-page":"26","article-title":"A multisite review of concomitant use of daptomycin and statins and the effect on CPK","author":"Lehman","year":"2016","journal-title":"Proceedings from the ID Week"},{"key":"2019061104405602700_CIT0015","doi-asserted-by":"crossref","first-page":"5726","DOI":"10.1128\/AAC.02910-14","article-title":"Musculoskeletal safety outcomes of patients receiving daptomycin with HMG-CoA reductase inhibitors","volume":"58","author":"Bland","year":"2014","journal-title":"Antimicrob Agents Chemother."},{"key":"2019061104405602700_CIT0016","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1093\/cid\/ciy287","article-title":"Statin coadministration increases the risk of daptomycin-associated myopathy","volume":"67","author":"Dare","year":"2018","journal-title":"Clin Infect Dis."},{"key":"2019061104405602700_CIT0017","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/eurheartj\/ehv043","article-title":"Statin-associated muscle symptoms: impact on statin therapy-European atherosclerosis society consensus panel statement on assessment, aetiology and management","volume":"36","author":"Stroes","year":"2015","journal-title":"Eur Heart J."},{"key":"2019061104405602700_CIT0018","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1002\/phar.1298","article-title":"Safety and effectiveness of daptomycin across a hospitalized obese population: results of a multicenter investigation in the southeastern United States","volume":"33","author":"Bookstaver","year":"2013","journal-title":"Pharmacotherapy."},{"key":"2019061104405602700_CIT0019","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ijantimicag.2016.04.022","article-title":"Safety of treatment with high-dose daptomycin in 102 patients with infective endocarditis","volume":"48","author":"Durante-Mangoni","year":"2016","journal-title":"Int J Antimicrob Agents."},{"key":"2019061104405602700_CIT0020","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1001\/archinte.163.5.553","article-title":"Risk for myopathy with statin therapy in high-risk patients","volume":"163","author":"Ballantyne","year":"2003","journal-title":"Arch Intern Med."},{"key":"2019061104405602700_CIT0021","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/jama.292.11.1307","article-title":"Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial","volume":"292","author":"de Lemos","year":"2004","journal-title":"Jama."},{"key":"2019061104405602700_CIT0022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP171764.APPGL","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology guidelines for management of dyslipidemia and prevention of cardiovascular disease","volume":"23(suppl 2)","author":"Jellinger","year":"2017","journal-title":"Endocr Pract."},{"key":"2019061104405602700_CIT0023","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1161\/01.CIR.0000012530.68333.C8","article-title":"Withdrawal of statins increases event rates in patients with acute coronary syndromes","volume":"105","author":"Heeschen","year":"2002","journal-title":"Circulation."},{"key":"2019061104405602700_CIT0024","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1001\/archinte.164.19.2162","article-title":"Early withdrawal of statin therapy in patients with non-ST-segment elevation myocardial infarction: national registry of myocardial infarction","volume":"164","author":"Spencer","year":"2004","journal-title":"Arch Intern Med."},{"key":"2019061104405602700_CIT0025","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-140-11-200406010-00006","article-title":"Association of statin therapy with outcomes of acute coronary syndromes: the GRACE study","volume":"140","author":"Spencer","year":"2004","journal-title":"Ann Intern Med."},{"key":"2019061104405602700_CIT0026","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1161\/01.CIR.102.25.3104","article-title":"Suppression of endothelial nitric oxide production after withdrawal of statin treatment is mediated by negative feedback regulation of rho GTPase gene transcription","volume":"102","author":"Laufs","year":"2000","journal-title":"Circulation."},{"key":"2019061104405602700_CIT0027","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.atherosclerosis.2007.12.029","article-title":"The creatine kinase response to eccentric exercise with atorvastatin 10 mg or 80 mg","volume":"200","author":"Kearns","year":"2008","journal-title":"Atherosclerosis."},{"key":"2019061104405602700_CIT0028","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/S0002-9149(01)01464-3","article-title":"Air force\/Texas coronary atherosclerosis prevention study (AFCAPS\/TexCAPS): additional perspectives on tolerability of long-term treatment with lovastatin","volume":"87","author":"Downs","year":"2001","journal-title":"Am J Cardiol."}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/76\/4\/206\/28791418\/zxy036.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T04:41:38Z","timestamp":1560228098000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/76\/4\/206\/5298223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,21]]},"references-count":28,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2019,1,21]]},"published-print":{"date-parts":[[2019,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ajhp\/zxy036","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,2,15]]},"published":{"date-parts":[[2019,1,21]]}}}